Schneider Electric S.E. (SBGSY)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	145,866	139,944	112,692	77,552	108,753	77,473
Market Cap Growth	10.60%	24.18%	45.31%	-28.69%	40.37%	36.97%
Enterprise Value	162,058	152,464	128,629	91,427	121,882	86,418
Last Close Price	51.75	49.02	39.34	26.93	37.11	27.00
PE Ratio	28.88	31.66	25.47	20.87	29.85	29.79
PS Ratio	3.16	3.54	2.84	2.12	3.31	2.52
PB Ratio	4.47	4.32	3.75	2.78	3.40	2.67
P/FCF Ratio	29.56	29.20	20.42	19.90	31.12	16.03
P/OCF Ratio	23.68	24.22	17.26	16.67	26.45	14.28
EV/Sales Ratio	3.53	3.86	3.24	2.50	3.71	2.81
EV/EBITDA Ratio	17.05	19.64	17.15	13.40	20.05	16.61
EV/EBIT Ratio	20.26	22.21	19.58	15.49	23.61	19.37
EV/FCF Ratio	32.84	31.81	23.31	23.46	34.88	17.89
Debt / Equity Ratio	0.61	0.52	0.56	0.63	0.39	0.49
Debt / EBITDA Ratio	2.10	2.07	2.14	2.44	1.96	2.53
Debt / FCF Ratio	4.06	3.52	3.03	4.47	3.60	2.92
Asset Turnover	0.64	0.61	0.61	0.61	0.56	0.53
Inventory Turnover	4.11	4.41	4.71	4.88	4.98	5.24
Quick Ratio	0.83	0.92	0.90	0.64	0.79	1.11
Current Ratio	1.14	1.23	1.22	0.91	1.09	1.36
Return on Equity (ROE)	15.96%	15.19%	15.65%	13.05%	12.63%	9.55%
Return on Assets (ROA)	6.95%	6.64%	6.34%	6.12%	5.46%	4.83%
Return on Capital (ROIC)	9.60%	9.22%	8.77%	8.46%	7.63%	6.82%
Return on Capital Employed (ROCE)	15.90%	14.30%	14.00%	14.70%	11.30%	10.00%
Earnings Yield	3.46%	3.16%	3.93%	4.79%	3.35%	3.36%
FCF Yield	3.38%	3.43%	4.90%	5.03%	3.21%	6.24%
Dividend Yield	1.21%	8.24%	9.83%	12.50%	8.89%	11.78%
Payout Ratio	50.95%	45.98%	44.14%	46.53%	45.16%	66.46%
Buyback Yield / Dilution	-0.34%	-0.44%	-0.25%	-0.08%	-1.27%	-0.01%
Total Shareholder Return	0.87%	7.80%	9.58%	12.41%	7.61%	11.77%

Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.